Cargando…

PMON336 Pfizer Registry of Outcomes in Growth hormone RESearch (PROGRES): A multi-country, non-interventional, prospective, cohort study of patients receiving human growth hormone treatments under routine clinical care

BACKGROUND: Children with growth hormone deficiency (GHD) are treated with recombinant human growth hormone (rhGH), usually administered as a daily subcutaneous injection. Long-acting hGH (LAGH) treatments (approved and in development) have the potential to improve adherence and treatment outcomes....

Descripción completa

Detalles Bibliográficos
Autores principales:	Geffner, Mitchell E, Ibanez, Lourdes, Maniatis, Aristides, Torre, Daria L, Huang, Carol, Darendelieler, Feyza, Dattani, Mehul, Maghnie, Mohamad, Phillip, Moshe, Dahlgren, Jovanna, Horikawa, Reiko, Gomez, Roy, Kelly, Scott P, Wajnrajch, Michael P
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Pediatric Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625236/ http://dx.doi.org/10.1210/jendso/bvac150.1306

Ejemplares similares

Growth, Endocrine Features, and Growth Hormone Treatment in Noonan Syndrome
por: Dahlgren, Jovanna, et al.
Publicado: (2022)

Safety and Efficacy of Pediatric Growth Hormone Therapy: Results From the Full KIGS Cohort
por: Maghnie, Mohamad, et al.
Publicado: (2022)

The first-year growth response to growth hormone treatment predicts the long-term prepubertal growth response in children
por: Kriström, Berit, et al.
Publicado: (2009)

SUN-336 Autocrine / Paracrine Growth Hormone (GH) Drives Multimodal Therapy Resistance in Growth Hormone Receptor (GHR)-expressing Human Cancers
por: Basu, Reetobrata, et al.
Publicado: (2019)

Response to Letter to the Editor From Virú-Loza and Chávez-Nomberto: “Safety and Efficacy of Pediatric Growth Hormone Therapy: Results From the Full KIGS Cohort”
por: Maghnie, Mohamad, et al.
Publicado: (2023)

RF26 | PMON332 Safety and Efficacy of Treatment with Lonapegsomatropin in Children with Growth Hormone Deficiency at Week 130 in the enliGHten Trial
por: Saenger, Paul, et al.
Publicado: (2022)

Treatment Burden of Weekly Somatrogon vs Daily Somatropin in Children With Growth Hormone Deficiency: A Randomized Study
por: Maniatis, Aristides K, et al.
Publicado: (2022)

SUN-457 Congenital Growth Hormone Deficiency Associated with Hip Disorders in Children and Adolescents
por: Baranski Lamback, Elisa, et al.
Publicado: (2019)

PMON64 Economic Burden of Growth Hormone Deficiency in a US Adult Population
por: Smith, Alden, et al.
Publicado: (2022)

Cardiovascular safety of growth hormone treatment in Noonan syndrome: real-world evidence
por: Romano, Alicia, et al.
Publicado: (2021)

Persistence with daily growth hormone among children and adolescents with growth hormone deficiency in the UK
por: Loftus, Jane, et al.
Publicado: (2022)

Models predicting the growth response to growth hormone treatment in short children independent of GH status, birth size and gestational age
por: Dahlgren, Jovanna, et al.
Publicado: (2007)

Effectiveness and Overall Safety of NutropinAq(®) for Growth Hormone Deficiency and Other Paediatric Growth Hormone Disorders: Completion of the International Cooperative Growth Study, NutropinAq(®) European Registry (iNCGS)
por: Coutant, Regis, et al.
Publicado: (2021)

Gene expression signatures predict response to therapy with growth hormone
por: Stevens, Adam, et al.
Publicado: (2021)

Different thresholds of tissue-specific dose-responses to growth hormone in short prepubertal children
por: Decker, Ralph, et al.
Publicado: (2012)

Safety and Efficacy of Pegvisomant in Pediatric Growth Hormone Excess
por: Tatsi, Christina, et al.
Publicado: (2021)

PMON313 Hyperinsulinemic Hypoglycemia and Growth Hormone Deficiency Secondary to 20p11 Deletion
por: Wee, Erica, et al.
Publicado: (2022)

OR17-4 Transcon Growth Hormone In The Treatment Of Pediatric Growth Hormone Deficiency: Results Of The Phase 3 Height Trial
por: Thornton, Paul, et al.
Publicado: (2019)

Growth Hormone Replacement Therapy: Transition from Adolescence to Adulthood
por: Geffner, Mitchell E.
Publicado: (2009)

A proteomic approach identified growth hormone-dependent nutrition markers in children with idiopathic short stature
por: Hellgren, Gunnel, et al.
Publicado: (2008)

Hyperestrogenism Affects Adult Height Outcome in Growth Hormone Treated Boys With Silver-Russell Syndrome
por: Kvernebo-Sunnergren, Kjersti, et al.
Publicado: (2018)

A Critical Appraisal of Growth Hormone Therapy in Growth Hormone Deficiency and Turner Syndrome Patients in Turkey
por: Yavaş Abalı, Zehra, et al.
Publicado: (2016)

THU170 Clinical And Immunological Response To Somatrogon In Two Siblings With A Homozygous Whole Gene Deletion Of The Growth Hormone 1 Gene
por: Gupta, Rahul, et al.
Publicado: (2023)

Psychometric Validation of the Growth Hormone Deficiency–Child Treatment Burden Measure (GHD-CTB) and the Growth Hormone Deficiency–Parent Treatment Burden Measure (GHD-PTB)
por: Brod, Meryl, et al.
Publicado: (2022)

OR10-06 Somatrogon Growth Hormone in the Treatment of Pediatric Growth Hormone Deficiency: Results of the Pivotal Pediatric Phase 3 Clinical Trial
por: Deal, Cheri L, et al.
Publicado: (2020)

PMON49 Checkpoint Inhibitor Induced Hypophysitis with Growth Hormone Deficiency and Implications for the Treatment of ACTH Deficiency
por: DeCherney, Stephen, et al.
Publicado: (2022)

PMON331 The Natural History of Pituitary Cysts in Patients with Growth Hormone Deficiency and Idiopathic Short Stature
por: Krasnow, Matthew, et al.
Publicado: (2022)

An eHealth Framework for Managing Pediatric Growth Disorders and Growth Hormone Therapy
por: Dimitri, Paul, et al.
Publicado: (2021)

Efficacy of growth hormone replacement on anthropometric outcomes, obesity, and lipids in children with optic nerve hypoplasia and growth hormone deficiency
por: Stewart, Carly, et al.
Publicado: (2016)

Psychometric Validation of the Growth Hormone Deficiency-Child Impact Measure (GHD-CIM)
por: Brod, Meryl, et al.
Publicado: (2021)

Outcomes in growth hormone-treated Noonan syndrome children: impact of PTPN11 mutation status
por: Jorge, Alexander A L, et al.
Publicado: (2022)

PMON330 The Relationship between Pituitary Volume and Chiari Malformation in Growth Hormone Deficiency and Idiopathic Short Stature
por: Manely, Sarah, et al.
Publicado: (2022)

PMON329 Survey of physician experience with once weekly somatrogon vs once daily somatropin regimen for the treatment of pediatric patients with growth hormone deficiency: results from a cross sectional, observational study
por: Gomez, Roy, et al.
Publicado: (2022)

Long-term Safety of Growth Hormone in Adults With Growth Hormone Deficiency: Overview of 15 809 GH-Treated Patients
por: Johannsson, Gudmundur, et al.
Publicado: (2022)

The Growth Hormone Deficiency (GHD) Reversal Trial: effect on final height of discontinuation versus continuation of growth hormone treatment in pubertal children with isolated GHD—a non-inferiority Randomised Controlled Trial (RCT)
por: Brettell, Elizabeth, et al.
Publicado: (2023)

Cost-consequence analysis for human recombinant growth hormone (r-hGH) treatment administered via different devices in children with growth hormone deficiency in Italy
por: Foo, Jason, et al.
Publicado: (2019)

RF13 | PMON133 A novel variant in an intron consensus sequence associated with familial growth hormone deficiency
por: Jee, Youn Hee, et al.
Publicado: (2022)

PMON68 Effect of an Amino-Acid Based Blend on Human Growth Hormone (hGH) and Fibromyalgia (FM) Symptoms
por: Beres, Adam, et al.
Publicado: (2022)

RF26 | PMON334 Once-Weekly Somapacitan in Growth Hormone Deficiency: 4-Year Efficacy and Safety Results from REAL 3, a Randomised Controlled Phase 2 Trial
por: Savendahl, Lars, et al.
Publicado: (2022)

THU166 A Minimum Data Set For The Monitoring Of Recombinant Human Growth Hormone (rhGH) Therapy In Children With Growth Hormone Deficiency (GHD)—A GloBE-Reg Initiative
por: Chen, Suet Ching, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ecm81b8d0i485rrgb5ata32v8h